CCLA Investment Management Purchases 98,121 Shares of Danaher Corporation $DHR

CCLA Investment Management raised its stake in shares of Danaher Corporation (NYSE:DHR) by 23.6% in the 2nd quarter, Holdings Channel reports. The firm owned 513,639 shares of the conglomerate’s stock after purchasing an additional 98,121 shares during the quarter. CCLA Investment Management’s holdings in Danaher were worth $101,423,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Sierra Ocean LLC raised its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the 1st quarter worth $31,000. Red Tortoise LLC raised its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Costello Asset Management INC bought a new position in Danaher during the 1st quarter worth $41,000. Finally, Ramirez Asset Management Inc. bought a new position in Danaher during the 2nd quarter worth $40,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on DHR shares. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. TD Cowen lifted their price objective on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Friday. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 price objective (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Finally, Evercore ISI lifted their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Performance

Shares of DHR opened at $223.03 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The stock has a 50-day moving average of $202.73 and a 200-day moving average of $198.57. The company has a market cap of $157.54 billion, a PE ratio of 45.99, a P/E/G ratio of 3.41 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period last year, the business posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 11.20% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.